choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Savella

Savella Newsletter
  • Tonix launches its new fibromyalgia drug in US 28 Nov 2025 10:45 GMT

    FDA was based on two late-stage studies, in which the drug … a number of already-available treatment options for fibromyalgia, including … ), and AbbVie's Savella (milnacipran), which are all also … to start a phase 2 trial in major depressive disorder …

  • Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain? 30 Sep 2025 13:11 GMT

    … inhibitor from Vertex Pharmaceuticals, has spurred further … drugs fail, doctors often move to off-label options including antidepressantsbiotech’s trials. Axsome is now planning a replacement trial … pivot toward new treatment strategies, including psychedelics …

  • Tonix ends 16-year hiatus in fibromyalgia treatment 18 Aug 2025 12:15 GMT

    … after claiming FDA approval for Tonmya, an oral drug used to … and AbbVie's Savella (milnacipran), which dominate the … of Washington School of Medicine said that fibromyalgia currently … quot;Tonmya is a novel treatment approach that targets nonrestorative …

  • TNX-102 SL Now Fourth FDA-Approved Treatment for Fibromyalgia 19 Aug 2025 04:50 GMT

    trials also demonstrated good tolerance of the treatment, as did a third trialPharmaceuticals announces FDA approval of Tonmya (cyclobenzaprine HCl sublingual tablets) for the treatment … #47;biotech/;forest-and-cypress-announce-fda-approval-of-savella-tm- …

  • Fibromyalgia Treatment Landscape: FDA Approves TONMYA, First New Therapy In 15 Years Delveinsight's Perspective On Market Impact, Competitive Landscape And Other Pipeline Therapies 22 Aug 2025 03:03 GMT

    … fibromyalgia treatment approved by the FDA … Phase 3 trials (RELIEF and … antidepressant medications. Explore the Fibromyalgia Drug Battle: TONMYA vs. LYRICA vs. CYMBALTA vs. SAVELLA … consulting services to pharmaceutical companies, biotechnology firms, and …

  • FDA approves landmark fibromyalgia drug that works like no other 18 Aug 2025 22:35 GMT

    … action. In clinical trials, this quick delivery … Executive Officer of Tonix Pharmaceuticals. “At Tonix, we … FDA-approved medications like Lyrica (pregabalin), Cymbalta (duloxetine) and Savelladrug is also currently in the trial stage for the treatment

  • Biotech Stocks Facing FDA Decision In August 2025 30 Jul 2025 15:53 GMT

    biotech companies whose drug candidates are at the FDAPharmaceuticals Inc. (IONS) Ionis Pharma's Donidalorsen, an investigational RNA-targeted medicinedrug, Rilzabrutinib, being developed for the treatment of immune thrombocytopenia, awaits the FDA

  • Fetzima interactions: Alcohol, medications, and other factors 25 Jun 2025 15:58 GMT

    medication Savella (milnacipran), which is very similar to Fetzima (levomilnacipran). Taking the drugtreatment with Fetzima, talk with your doctor. Fetzima interactions with vaccinesantidepressantsFDA. A boxed warning alerts doctors and patients about drug

  • Woman held on $10K cash bail in drug case, could face 36 years in prison 02 Jul 2025 12:36 GMT

    … 93 grams of meth, drug paraphernalia and a stolen pressure … along with drug paraphernalia, according to the complaint. Darwin Savella, 41, … to deliver by complicity. Savella told police he gave someone … the complaint. Valencia and Savella both face 15 years in …

  • 5 arrested in Dededo drug bust; meth, stolen items seized 01 Jul 2025 10:58 GMT

    … 10 grams of methamphetamine, cash, drug paraphernalia, and stolen property during … Department. Arrested were: Darwin Papa Savella Danny Sangil Valencia Melissa Mad … also found several articles of drug paraphernalia containing significant residue, along …

Satisfied with the content?

Continue to create your account.